Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Voichita Bar Ad

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
Journal of Neuro-Oncology|April 15, 2014
Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trialWenyin Shi, Yaacov Richard Lawrence, Hak Choy, et al.
International Journal of Radiation Oncology, Biology, Physics|June 20, 2022
Two-Year Tumor Outcomes of a Phase 2B, Randomized, Double-Blind Trial of Avasopasem Manganese (GC4419) Versus Placebo to Reduce Severe Oral Mucositis Owing to Concurrent Radiation Therapy and Cisplatin for Head and Neck CancerCarryn M Anderson, Christopher M Lee, Deborah Saunders, et al.
Journal of Neuro-Oncology|March 25, 2020
Initial experience with scalp sparing radiation with concurrent temozolomide and tumor treatment fields (SPARE) for patients with newly diagnosed glioblastomaAndrew Song, Voichita Bar-Ad, Nina Martinez, et al.
Journal for Immunotherapy of Cancer|August 3, 2023
Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neckJennifer M Johnson, Ioannis A Vathiotis, Larry A Harshyne, et al.
International Journal of Radiation Oncology, Biology, Physics|January 16, 2023
PREVLAR: Phase 2a Randomized Trial to Assess the Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Head and Neck ChemoradiotherapyMarcelo Bonomi, Dukagjin M Blakaj, Rafi Kabarriti, et al.
Journal of Neuro-Oncology|January 30, 2016
Phase I trial of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomasWenyin Shi, Joshua D Palmer, Maria Werner-Wasik, et al.
Journal of Neuro-Oncology|January 10, 2018
Correction to: Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatmentWenyin Shi, Erik S Blomain, Joshua Siglin, et al.
Journal of Neuro-Oncology|December 14, 2017
Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatmentWenyin Shi, Erik S Blomain, Joshua Siglin, et al.
Frontiers in Oncology|May 16, 2022
Scalp-Sparing Radiation With Concurrent Temozolomide and Tumor Treating Fields (SPARE) for Patients With Newly Diagnosed GlioblastomaRyan Miller, Andrew Song, Ayesha Ali, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|October 13, 2020
Feasibility of removable balloon implant for simultaneous magnetic nanoparticle heating and HDR brachytherapy of brain tumor resection cavitiesPaul R Stauffer, Dario B Rodrigues, Robert Goldstein, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Journal of Neuro-Oncology|April 15, 2014
Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trialWenyin Shi, Yaacov Richard Lawrence, Hak Choy, et al.
International Journal of Radiation Oncology, Biology, Physics|June 20, 2022
Two-Year Tumor Outcomes of a Phase 2B, Randomized, Double-Blind Trial of Avasopasem Manganese (GC4419) Versus Placebo to Reduce Severe Oral Mucositis Owing to Concurrent Radiation Therapy and Cisplatin for Head and Neck CancerCarryn M Anderson, Christopher M Lee, Deborah Saunders, et al.
Journal of Neuro-Oncology|March 25, 2020
Initial experience with scalp sparing radiation with concurrent temozolomide and tumor treatment fields (SPARE) for patients with newly diagnosed glioblastomaAndrew Song, Voichita Bar-Ad, Nina Martinez, et al.
Journal for Immunotherapy of Cancer|August 3, 2023
Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neckJennifer M Johnson, Ioannis A Vathiotis, Larry A Harshyne, et al.
International Journal of Radiation Oncology, Biology, Physics|January 16, 2023
PREVLAR: Phase 2a Randomized Trial to Assess the Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Head and Neck ChemoradiotherapyMarcelo Bonomi, Dukagjin M Blakaj, Rafi Kabarriti, et al.
Journal of Neuro-Oncology|January 30, 2016
Phase I trial of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomasWenyin Shi, Joshua D Palmer, Maria Werner-Wasik, et al.
Journal of Neuro-Oncology|January 10, 2018
Correction to: Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatmentWenyin Shi, Erik S Blomain, Joshua Siglin, et al.
Journal of Neuro-Oncology|December 14, 2017
Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatmentWenyin Shi, Erik S Blomain, Joshua Siglin, et al.
Frontiers in Oncology|May 16, 2022
Scalp-Sparing Radiation With Concurrent Temozolomide and Tumor Treating Fields (SPARE) for Patients With Newly Diagnosed GlioblastomaRyan Miller, Andrew Song, Ayesha Ali, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|October 13, 2020
Feasibility of removable balloon implant for simultaneous magnetic nanoparticle heating and HDR brachytherapy of brain tumor resection cavitiesPaul R Stauffer, Dario B Rodrigues, Robert Goldstein, et al.
Pageof 10